Trial intelligence / Profile preview

Stavudine vs Placebo in Recent HIV Infection

NCT00002349Phase 2Completed

Sponsor
Bristol Myers Squibb
Start
Jan 1995
Primary completion
May 1999
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of stavudine in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started Jan 1995; status: completed.

02

Drugs

stavudine
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00002349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call